Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference

The new mini-textbook by Kamps & Hoffmann
PDF, 110 pages


  Lung Cancer

  Free Subscription


10.02.2020

1 Am J Clin Oncol
6 Anticancer Res
1 Arch Bronconeumol
1 BMJ
1 Br J Cancer
1 Cancer
1 Cancer Lett
1 Cancer Sci
1 Clin Exp Metastasis
1 Clin Lung Cancer
1 Eur J Cancer
2 Eur J Cardiothorac Surg
1 Eur Respir J
2 Int J Cancer
2 Int J Radiat Oncol Biol Phys
1 J Cancer Res Clin Oncol
1 J Clin Invest
1 J Surg Oncol
2 J Thorac Cardiovasc Surg
3 J Thorac Oncol
2 Lancet Oncol
2 Lung Cancer (Auckl)
1 N Engl J Med
3 Oncogene
2 Oncol Rep
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Clin Oncol

  1. BHANDARI S, Kumar R, Pham D, Gaskins J, et al
    Treatment Timing in Small Cell Lung Cancer, a National Cancer Database Analysis.
    Am J Clin Oncol. 2020 Jan 31. doi: 10.1097/COC.0000000000000676.
    PubMed     Text format     Abstract available


    Anticancer Res

  2. NAKAMURA Y, Miyazaki K, Aiko N, Misumi Y, et al
    Efficacy of PD-1 Inhibitors in Older Non-small Cell Lung Cancer Patients.
    Anticancer Res. 2020;40:923-928.
    PubMed     Text format     Abstract available

  3. CHANVORACHOTE P, Sriratanasak N, Nonpanya N
    C-myc Contributes to Malignancy of Lung Cancer: A Potential Anticancer Drug Target.
    Anticancer Res. 2020;40:609-618.
    PubMed     Text format     Abstract available

  4. KITA Y, Go T, Nakashima N, Liu D, et al
    Inhibition of Cell-surface Molecular GPR87 With GPR87-suppressing Adenoviral Vector Disturb Tumor Proliferation in Lung Cancer Cells.
    Anticancer Res. 2020;40:733-741.
    PubMed     Text format     Abstract available

  5. IOANNIDIS G, Papadaki C, Lagoudaki E, Tzardi M, et al
    Messenger-RNA Expression of Five Gemcitabine Sensitivity-related Genes Predicting Outcome in Advanced-stage Non-small Cell Lung Cancer.
    Anticancer Res. 2020;40:901-913.
    PubMed     Text format     Abstract available

  6. PEZZUTO A, Cappuzzo F, D'Arcangelo M, Ciccozzi M, et al
    Prognostic Value of p16 Protein in Patients With Surgically Treated Non-small Cell Lung Cancer; Relationship With Ki-67 and PD-L1.
    Anticancer Res. 2020;40:983-990.
    PubMed     Text format     Abstract available

  7. NAKANO T, Go T, Nakashima N, Liu D, et al
    Overexpression of Antiapoptotic MCL-1 Predicts Worse Overall Survival of Patients With Non-small Cell Lung Cancer.
    Anticancer Res. 2020;40:1007-1014.
    PubMed     Text format     Abstract available


    Arch Bronconeumol

  8. CARRICO F, Alves RM, Luis F
    Foreign Body Aspiration Simulating Lung Cancer.
    Arch Bronconeumol. 2020 Feb 1. pii: S0300-2896(19)30624.
    PubMed     Text format    


    BMJ

  9. TREASURE T
    Questioning the benefit of lung metastasectomy in colorectal cancer.
    BMJ. 2020;368:m264.
    PubMed     Text format    


    Br J Cancer

  10. ACHA-SAGREDO A, Uko B, Pantazi P, Bediaga NG, et al
    Long non-coding RNA dysregulation is a frequent event in non-small cell lung carcinoma pathogenesis.
    Br J Cancer. 2020 Feb 5. pii: 10.1038/s41416-020-0742.
    PubMed     Text format     Abstract available


    Cancer

  11. TAKAHAMA T, Azuma K, Shimokawa M, Takeda M, et al
    Plasma screening for the T790M mutation of EGFR and phase 2 study of osimertinib efficacy in plasma T790M-positive non-small cell lung cancer: West Japan Oncology Group 8815L/LPS study.
    Cancer. 2020 Feb 5. doi: 10.1002/cncr.32749.
    PubMed     Text format     Abstract available


    Cancer Lett

  12. XIAO R, Ding C, Zhu H, Liu X, et al
    Suppression of asparagine synthetase enhances the antitumor potency of ART and artemalogue SOMCL-14-221 in non-small cell lung cancer.
    Cancer Lett. 2020 Jan 31. pii: S0304-3835(20)30049.
    PubMed     Text format     Abstract available


    Cancer Sci

  13. OSUMI H, Horiguchi H, Kadomatsu T, Tashiro K, et al
    Tumor cell-derived ANGPTL2 establishes a preference for glycolytic metabolism in lung cancer cells.
    Cancer Sci. 2020 Feb 3. doi: 10.1111/cas.14337.
    PubMed     Text format     Abstract available


    Clin Exp Metastasis

  14. LEE SW, Kim YS, Sung SY, Kwak YK, et al
    Upfront radiosurgery plus targeted agents followed by active brain control using radiosurgery delays neurological death in non-small cell lung cancer with brain metastasis.
    Clin Exp Metastasis. 2020 Feb 1. pii: 10.1007/s10585-020-10022.
    PubMed     Text format     Abstract available


    Clin Lung Cancer

  15. SHAH R, Lester JF
    Tyrosine Kinase Inhibitors for the Treatment of EGFR Mutation-Positive Non-Small-Cell Lung Cancer: A Clash of the Generations.
    Clin Lung Cancer. 2019 Dec 20. pii: S1525-7304(19)30346.
    PubMed     Text format     Abstract available


    Eur J Cancer

  16. FELIP E, Ardizzoni A, Ciuleanu T, Cobo M, et al
    CheckMate 171: A phase 2 trial of nivolumab in patients with previously treated advanced squamous non-small cell lung cancer, including ECOG PS 2 and elderly populations.
    Eur J Cancer. 2020;127:160-172.
    PubMed     Text format     Abstract available


    Eur J Cardiothorac Surg

  17. OPITZ I, Patella M, Payrard L, Perentes JY, et al
    Prognostic factors of oligometastatic non-small-cell lung cancer following radical therapy: a multicentre analysis.
    Eur J Cardiothorac Surg. 2020 Feb 3. pii: 5721431. doi: 10.1093.
    PubMed     Text format     Abstract available

  18. YANG MZ, Hou X, Li JB, Cai JS, et al
    Impact of L4 lymph node dissection on long-term survival in left-side operable non-small-cell lung cancer: a propensity score matching study.
    Eur J Cardiothorac Surg. 2020 Feb 4. pii: 5722182. doi: 10.1093.
    PubMed     Text format     Abstract available


    Eur Respir J

  19. BERGHMANS T, Dingemans AM, Hendriks LEL, Cadranel J, et al
    Immunotherapy for nonsmall cell lung cancer: a new therapeutic algorithm.
    Eur Respir J. 2020;55.
    PubMed     Text format    


    Int J Cancer

  20. BRASKY TM, Ray RM, Navarro SL, Schenk JM, et al
    Supplemental one-carbon metabolism related B vitamins and lung cancer risk in the Women's Health Initiative.
    Int J Cancer. 2020 Feb 6. doi: 10.1002/ijc.32913.
    PubMed     Text format     Abstract available

  21. FIDLER-BENAOUDIA MM, Torre LA, Bray F, Ferlay J, et al
    Lung cancer incidence in young women vs. young men: A systematic analysis in 40 countries.
    Int J Cancer. 2020 Feb 5. doi: 10.1002/ijc.32809.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  22. PENG J, Pond G, Donovan E, Ellis PM, et al
    A Comparison of Radiation Techniques in Patients Treated With Concurrent Chemoradiation for Stage III Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2020 Jan 29. pii: S0360-3016(19)34545.
    PubMed     Text format     Abstract available

  23. GIULIANI ME, Robinson CG, Salama JK, Daly ME, et al
    Oligoreview of Non-Small Cell Lung Cancer Oligometastases.
    Int J Radiat Oncol Biol Phys. 2020;106:455-459.
    PubMed     Text format    


    J Cancer Res Clin Oncol

  24. TAKADA K, Yoneshima Y, Tanaka K, Okamoto I, et al
    Clinical impact of skeletal muscle area in patients with non-small cell lung cancer treated with anti-PD-1 inhibitors.
    J Cancer Res Clin Oncol. 2020 Feb 5. pii: 10.1007/s00432-020-03146.
    PubMed     Text format     Abstract available


    J Clin Invest

  25. LIN M, Luo H, Liang S, Chen J, et al
    Pembrolizumab plus allogeneic NK cells in advanced non-small cell lung cancer patients.
    J Clin Invest. 2020 Feb 6. pii: 132712. doi: 10.1172/JCI132712.
    PubMed     Text format     Abstract available


    J Surg Oncol

  26. CROWN A, Rocha FG, Raghu P, Lin B, et al
    Impact of initial imaging with gallium-68 dotatate PET/CT on diagnosis and management of patients with neuroendocrine tumors.
    J Surg Oncol. 2020;121:480-485.
    PubMed     Text format     Abstract available


    J Thorac Cardiovasc Surg

  27. ZHENG R, Shen Q, Mardekian S, Solomides C, et al
    Molecular profiling of key driver genes improves staging accuracy in multifocal non-small cell lung cancer.
    J Thorac Cardiovasc Surg. 2019 Dec 20. pii: S0022-5223(19)39883.
    PubMed     Text format     Abstract available

  28. RANDHAWA SK, Puri V
    Commentary: The changing risk paradigm in lung cancer: Are we opening Pandora's box?
    J Thorac Cardiovasc Surg. 2020 Jan 3. pii: S0022-5223(19)43494.
    PubMed     Text format    


    J Thorac Oncol

  29. COHEN D, Hondelink LM, Solleveld-Westerink N, Uljee SM, et al
    Optimizing mutation and fusion detection in Non-Small Cell Lung Cancer by sequential DNA and RNA sequencing.
    J Thorac Oncol. 2020 Jan 31. pii: S1556-0864(20)30093.
    PubMed     Text format     Abstract available

  30. POIRIER JT, George J, Owonikoko TK, Berns A, et al
    New approaches to small cell lung cancer therapy : from the laboratory to the clinic.
    J Thorac Oncol. 2020 Feb 1. pii: S1556-0864(20)30056.
    PubMed     Text format     Abstract available

  31. BACKMAN M, La Fleur L, Kurppa P, Djureinovic D, et al
    Characterization of patterns of immune cell infiltration in non-small cell lung cancer (NSCLC).
    J Thorac Oncol. 2020 Feb 3. pii: S1556-0864(20)30015.
    PubMed     Text format     Abstract available


    Lancet Oncol

  32. SEQUIST LV, Han JY, Ahn MJ, Cho BC, et al
    Osimertinib plus savolitinib in patients with EGFR mutation-positive, MET-amplified, non-small-cell lung cancer after progression on EGFR tyrosine kinase inhibitors: interim results from a multicentre, open-label, phase 1b study.
    Lancet Oncol. 2020 Feb 3. pii: S1470-2045(19)30785.
    PubMed     Text format     Abstract available

  33. SCHMID S, Fruh M, Peters S
    Targeting MET in EGFR resistance in non-small-cell lung cancer-ready for daily practice?
    Lancet Oncol. 2020 Feb 3. pii: S1470-2045(19)30859.
    PubMed     Text format    


    Lung Cancer (Auckl)

  34. CHENG YY, Rath EM, Linton A, Yuen ML, et al
    The Current Understanding Of Asbestos-Induced Epigenetic Changes Associated With Lung Cancer.
    Lung Cancer (Auckl). 2020;11:1-11.
    PubMed     Text format     Abstract available

  35. GADGEEL S, Shaw AT, Barlesi F, Crino L, et al
    Time To Response In Patients With Advanced Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small-Cell Lung Cancer (NSCLC) Receiving Alectinib In The Phase II NP28673 And NP28761 Studies.
    Lung Cancer (Auckl). 2019;10:125-130.
    PubMed     Text format     Abstract available


    N Engl J Med

  36. RAMALINGAM SS, Vansteenkiste J, Planchard D, Cho BC, et al
    Overall Survival with Osimertinib in Untreated, EGFR-Mutated Advanced NSCLC.
    N Engl J Med. 2020;382:41-50.
    PubMed     Text format     Abstract available


    Oncogene

  37. QI M, Dai D, Liu J, Li Z, et al
    AIM2 promotes the development of non-small cell lung cancer by modulating mitochondrial dynamics.
    Oncogene. 2020 Jan 31. pii: 10.1038/s41388-020-1176.
    PubMed     Text format     Abstract available

  38. TONG X, Wang S, Lei Z, Li C, et al
    MYOCD and SMAD3/SMAD4 form a positive feedback loop and drive TGF-beta-induced epithelial-mesenchymal transition in non-small cell lung cancer.
    Oncogene. 2020 Feb 6. pii: 10.1038/s41388-020-1189.
    PubMed     Text format     Abstract available

  39. REBOLLIDO-RIOS R, Venton G, Sanchez-Redondo S, Iglesias I Felip C, et al
    Dual disruption of aldehyde dehydrogenases 1 and 3 promotes functional changes in the glutathione redox system and enhances chemosensitivity in nonsmall cell lung cancer.
    Oncogene. 2020 Feb 3. pii: 10.1038/s41388-020-1184.
    PubMed     Text format     Abstract available


    Oncol Rep

  40. LI J, Li X, Zhang C, Zhang C, et al
    A signature of tumor immune microenvironment genes associated with the prognosis of nonsmall cell lung cancer.
    Oncol Rep. 2020 Jan 14. doi: 10.3892/or.2020.7464.
    PubMed     Text format     Abstract available

  41. LI Y, Ma C, Qian M, Wen Z, et al
    [Retracted] Downregulation of NOB1 suppresses the proliferation and tumor growth of nonsmall cell lung cancer in vitro and in vivo.
    Oncol Rep. 2020 Jan 29. doi: 10.3892/or.2020.7483.
    PubMed     Text format     Abstract available


    PLoS One

  42. LU J, Zang H, Zheng H, Zhan Y, et al
    Overexpression of p-Akt, p-mTOR and p-eIF4E proteins associates with metastasis and unfavorable prognosis in non-small cell lung cancer.
    PLoS One. 2020;15:e0227768.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: